Antibodies binding to CD3 and CD19
US11780920B2 · kind B2 · utility
0Cited by
27References
59Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2021 |
| Grant date | Oct 10, 2023 |
| Priority date | — |
| Expiry date | Aug 3, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally relates to antibodies that bind to CD3 and CD19, e.g. for activating T cells. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies, and to methods of using them in the treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.